DexCom CEO Kevin Sayer's 2018 pay jumps 21% to $9.6M
DexCom reports 2018 executive compensation
By ExecPay News
Published: April 19, 2019
DexCom reported fiscal year 2018 executive compensation information on April 19, 2019.
In 2018, five DexCom executives received on average a compensation package of $4.5M, a 37% increase compared to previous year.
Average pay of disclosed executives at DexCom
Kevin Sayer, Chief Executive Officer, received $9.6M in total, which increased by 21% compared to 2017. 80% of Sayer's compensation, or $7.7M, was in stock awards. Sayer also received $1.3M in non-equity incentive plan, $601K in salary, as well as $22K in other compensation.
For fiscal year 2018, the median employee pay was $80,723 at DexCom. Therefore, the ratio of Kevin Sayer's pay to the median employee pay was 118 to one.
Quentin S. Blackford, Chief Financial Officer, received a compensation package of $3.4M, which decreased by 34% compared to previous year. 68% of the compensation package, or $2.3M, was in stock awards.
Richard Doubleday, EVP, Chief Commercial Officer, earned $3.2M in 2018, a 10% increase compared to previous year.
Andrew Balo, EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development, received $3.2M in 2018, which increases by 5% compared to 2017.
Steven R. Pacelli, EVP, Strategy and Corporate Development, earned $3.2M in 2018, a 9% increase compared to previous year.
Related executives
Kevin Sayer
DexCom
Chief Executive Officer
Quentin Blackford
DexCom
Chief Financial Officer
Andrew Balo
DexCom
EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development
Richard Doubleday
DexCom
EVP, Chief Commercial Officer
Steven Pacelli
DexCom
EVP, Strategy and Corporate Development
You may also like
Source: SEC filing on April 19, 2019.